Skip to main content

Table 2 Median values of angiogenic biomarkers and odds of death or bacteremia

From: Biomarkers of endothelial dysfunction predict sepsis mortality in young infants: a matched case-control study

Biomarker

Death (n = 18) median [IQR]

Survivor (n = 52) median [IQR]

aOR (95% CI)

p -value*

Bacteremia (n = 10) median [IQR]

Non-bacteremia (n = 30) median [IQR]

aOR (95% CI)

p -value*

Combined Outcome (n = 25) median [IQR]

Control (n = 73) median [IQR]

aOR (95% CI)

p -value*

Ang-1 (ng/mL)

11.7 [4.7, 21.5]

15.8 [10.5, 25.0]

0.51 (0.22, 1.19)

0.119

11.2 [6.0, 20.4]

14.7 [8.7, 26.2]

0.49 (0.17, 1.44)

0.194

11.2 [5.7, 20.4]

15.2 [8.9, 25.0]

0.54 (0.26, 1.10)

0.089

Ang-2 (ng/mL)

5.4 [3.1, 10.1]

3.3 [2.1, 4.1]

2.50 (1.13, 5.54)

0.024

4.1 [2.6, 6.1]

3.4 [1.2, 5.0]

6.12 (0.85, 44.00)

0.072

4.9 [2.8, 7.1]

3.3 [2.0, 4.1]

3.20 (1.40, 7.34)

0.006

Ang 2:1 ratio

0.48 [0.25, 0.87]

0.21 [0.10, 0.31]

2.29 (1.16, 4.46)

0.016

0.28 [0.20, 0.46]

0.20 [0.01, 0.31]

5.72 (1.07, 30.50)

0.041

0.28 [0.20, 0.46]

0.21 [0.01, 0.31]

2.56 (1.35, 4.87)

0.004

sICAM (ng/mL)

276.0 [160.9, 484.7]

197.2 [150.1, 346.8]

14.11 (1.4, 137.83)

0.023

265.1 [146.3, 398.8]

161.0 [125.0, 222.9]

26.72 (0.84, 846.9)

0.062

262.0 [146.3, 409.1]

179.9 [144.0, 272.6]

10.25 (2.04, 51.34)

0.005

sVCAM (ng/mL)

1236.6 [950.8, 1544.3]

1154.5 [884.6, 1071.0]

2.38 (0.56, 10.04)

0.239

1166.6 [795.2, 1410.3]

1149.9 [861.1, 1552.7]

1.66 (0.26, 10.67)

0.594

1289.7 [950.8, 1541.1]

1168.0 [886.2, 1647.3]

2.77 (0.80, 9.56)

0.149

  1. aOR adjusted odds ratio, CI confidence interval, Ang-1 angiopoietin-1, Ang-2 angiopoietin-2, Ang2:1 ratio of Ang-2 to Ang-1, sICAM soluble intercellular adhesion molecule-1, sVCAM soluble vascular adhesion molecule 1, IQR inter-quartile range
  2. *P-value for conditional logistic regression for sex, lethargy and prior antibiotic exposure for Death outcome; sex and prior antibiotic exposure for Bacteremia outcome; sex, lethargy, temperature and prior antibiotic exposure for combined outcome. Biomarkers were log transformed
  3. Comparisons with p-value less than or equal to 0.05 marked in bold, and less than or equal to 0.10 marked in italics